{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:42:40Z","timestamp":1789522960738,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","issue":"3-5","content-domain":{"domain":["drupjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.drup.2013.10.002","type":"journal-article","created":{"date-parts":[[2013,10,26]],"date-time":"2013-10-26T01:15:19Z","timestamp":1382750119000},"page":"73-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the \u201cseesaw effect\u201d: Taking advantage of the back door left open?"],"prefix":"10.1016","volume":"16","author":[{"given":"Jessica K.","family":"Ortwine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Werth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Sakoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Rybak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2013.10.002_bib0005","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/jac\/dkh350","article-title":"Vancomycin-induced deletion of the methicillin resistance gene mecA in Staphylococcus aureus","volume":"54","author":"Adhikari","year":"2004","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0010","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ijantimicag.2007.07.011","article-title":"Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA)","volume":"30","author":"Appelbaum","year":"2007","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1016\/j.drup.2013.10.002_bib0015","series-title":"The 23rd Annual European Congress of Clinical Microbiology and Infectious Diseases","article-title":"Correlation of ceftaroline (CPT) susceptibility to vancomycin, teicoplanin and daptomycin against methicillin-resistant Staphylococcus aureus (MRSA): an observed \u201cseesaw effect\u201d","author":"Barber","year":"2013"},{"key":"10.1016\/j.drup.2013.10.002_bib0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1749-6632.2012.06819.x","article-title":"Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall","volume":"1277","author":"Bayer","year":"2013","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.drup.2013.10.002_bib0025","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/AAC.00502-12","article-title":"Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics","volume":"56","author":"Berti","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0030","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1517\/14656566.2012.685718","article-title":"Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection","volume":"13","author":"Casapao","year":"2012","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0035","unstructured":"CDC, 2012. CDC Reminds Clinical Laboratories and Healthcare Infection Preventionists of their Role in the Search and Containment of Vancomycin-Resistant Staphylococcus aureus (VRSA)."},{"issue":"Suppl. 2","key":"10.1016\/j.drup.2013.10.002_bib0040","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.1086\/513854","article-title":"Penicillin-binding protein-mediated resistance in pneumococci and staphylococci","volume":"179","author":"Chambers","year":"1999","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.drup.2013.10.002_bib0045","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0006-291X(66)90188-4","article-title":"Compounds formed between nucleotides related to the biosynthesis of bacterial cell wall and vancomycin","volume":"24","author":"Chatterjee","year":"1966","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.drup.2013.10.002_bib0050","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1128\/AAC.43.7.1747","article-title":"Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin","volume":"43","author":"Climo","year":"1999","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0055","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkt317","article-title":"Resurgence of penicillin-susceptible Staphylococcus aureus at a hospital in New York State, USA","author":"Crane","year":"2013","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1128\/JCM.41.1.5-14.2003","article-title":"Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus","volume":"41","author":"Cui","year":"2003","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1016\/j.drup.2013.10.002_bib0065","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.50.3.1079-1082.2006","article-title":"Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus","volume":"50","author":"Cui","year":"2006","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0070","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/cid\/cir340","article-title":"Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding","volume":"53","author":"Dhand","year":"2011","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.drup.2013.10.002_bib0075","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.1128\/JB.186.21.7141-7148.2004","article-title":"Tertiary structure of Staphylococcus aureus cell wall murein","volume":"186","author":"Dmitriev","year":"2004","journal-title":"Journal of Bacteriology"},{"key":"10.1016\/j.drup.2013.10.002_bib0080","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ijantimicag.2009.12.022","article-title":"In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin\/clavulanic acid or ampicillin","volume":"35","author":"Entenza","year":"2010","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1016\/j.drup.2013.10.002_bib0085","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1128\/AAC.45.11.3070-3075.2001","article-title":"Role of penicillin-binding protein 4 in expression of vancomycin resistance among clinical isolates of oxacillin-resistant Staphylococcus aureus","volume":"45","author":"Finan","year":"2001","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0090","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/AAC.05473-11","article-title":"In vitro pharmacodynamics of vancomycin and cefazolin alone and in combination against methicillin-resistant Staphylococcus aureus","volume":"56","author":"Hagihara","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0095","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/mdr.1996.2.193","article-title":"Effects of penicillin-binding protein 4 overproduction in Staphylococcus aureus","volume":"2","author":"Henze","year":"1996","journal-title":"Microbial Drug Resistance"},{"key":"10.1016\/j.drup.2013.10.002_bib0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1473-3099(01)00091-3","article-title":"Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance","volume":"1","author":"Hiramatsu","year":"2001","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/j.drup.2013.10.002_bib0105","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/AAC.01365-08","article-title":"Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA","volume":"53","author":"Horne","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0110","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1126\/science.99.2579.452","article-title":"Extraction of a highly potent penicillin inactivator from penicillin resistant staphylococci","volume":"99","author":"Kirby","year":"1944","journal-title":"Science"},{"key":"10.1016\/j.drup.2013.10.002_bib0115","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1128\/AAC.00019-10","article-title":"Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae","volume":"54","author":"Kosowska-Shick","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0120","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0021-9258(17)38141-3","article-title":"A membrane enzyme from Staphylococcus aureus which catalyzes transpeptidase, carboxypeptidase, and penicillinase activities","volume":"253","author":"Kozarich","year":"1978","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.drup.2013.10.002_bib0125","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1128\/AAC.00533-10","article-title":"Development of daptomycin nonsusceptibility with heterogeneous vancomycin-intermediate resistance and oxacillin susceptibility in methicillin-resistant Staphylococcus aureus during high-dose daptomycin treatment","volume":"54","author":"Lee","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0130","doi-asserted-by":"crossref","first-page":"pe42103","DOI":"10.1371\/journal.pone.0042103","article-title":"Synergy between vancomycin and nafcillin against Staphylococcus aureus in an in vitro pharmacokinetic\/pharmacodynamic model","volume":"7","author":"Leonard","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2013.10.002_bib0135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the infectious diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary","volume":"52","author":"Liu","year":"2011","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.drup.2013.10.002_bib0140","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","article-title":"Staphylococcus aureus infections","volume":"339","author":"Lowy","year":"1998","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.drup.2013.10.002_bib0145","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1128\/AAC.01609-09","article-title":"Fluorescence microscopy demonstrates enhanced targeting of telavancin to the division septum of Staphylococcus aureus","volume":"54","author":"Lunde","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0150","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijmm.2009.08.015","article-title":"Regulation of antibiotic resistance in Staphylococcus aureus","volume":"300","author":"McCallum","year":"2010","journal-title":"International Journal of Medical Microbiology"},{"key":"10.1016\/j.drup.2013.10.002_bib0155","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cit560","article-title":"The empirical combination of vancomycin and a beta-lactam for staphylococcal bacteremia","author":"McConeghy","year":"2013","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.drup.2013.10.002_bib0160","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1128\/AAC.01525-12","article-title":"beta-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives","volume":"56","author":"Mehta","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0165","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1128\/AAC.00049-08","article-title":"Staphylococcus aureus PBP4 is essential for beta-lactam resistance in community-acquired methicillin-resistant strains","volume":"52","author":"Memmi","year":"2008","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0170","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/infdis\/jis482","article-title":"Reduced susceptibility to host-defense cationic peptides and daptomycin coemerge in methicillin-resistant Staphylococcus aureus from daptomycin-naive bacteremic patients","volume":"206","author":"Mishra","year":"2012","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.drup.2013.10.002_bib0175","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1128\/AAC.01682-08","article-title":"Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus","volume":"53","author":"Mishra","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0180","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1128\/AAC.02192-12","article-title":"Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant beta-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment","volume":"57","author":"Moise","year":"2013","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0185","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1128\/AAC.41.8.1788","article-title":"Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus","volume":"41","author":"Moreira","year":"1997","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0190","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.1073\/pnas.0609839104","article-title":"Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing","volume":"104","author":"Mwangi","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.drup.2013.10.002_bib0195","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1128\/AAC.01164-07","article-title":"Spontaneous deletion of the methicillin resistance determinant, mecA, partially compensates for the fitness cost associated with high-level vancomycin resistance in Staphylococcus aureus","volume":"52","author":"Noto","year":"2008","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0200","first-page":"24","article-title":"Micrococcus poisoning","volume":"17","author":"Ogston","year":"1882","journal-title":"Journal of Anatomy and Physiology"},{"key":"10.1016\/j.drup.2013.10.002_bib0205","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1128\/AAC.00869-07","article-title":"daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations","volume":"52","author":"Rose","year":"2008","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0210","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1128\/AAC.00797-12","article-title":"Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity","volume":"56","author":"Rose","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0215","series-title":"The 52nd Annual Interscience Conference of Antimicrobial Agents and Chemotherapy","article-title":"Thickened cell wall as a mechanism for increased telavancin minimum inhibitory concentration (MIC) in methicillin-resistant Staphylococcus aureus (MRSA)","author":"Ryan","year":"2012"},{"key":"10.1016\/j.drup.2013.10.002_bib0220","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/JCM.00582-08","article-title":"Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007)","volume":"46","author":"Rybak","year":"2008","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1016\/j.drup.2013.10.002_bib0225","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/AAC.50.4.1581-1585.2006","article-title":"Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin","volume":"50","author":"Sakoulas","year":"2006","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0230","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1128\/AAC.05551-11","article-title":"Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium","volume":"56","author":"Sakoulas","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0235","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/jac\/dki316","article-title":"Loss of mecA gene in Staphylococcus epidermidis after prolonged therapy with vancomycin","volume":"56","author":"Sendi","year":"2005","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0240","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1128\/JCM.41.4.1687-1693.2003","article-title":"Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotics administered for chemotherapy","volume":"41","author":"Sieradzki","year":"2003","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1016\/j.drup.2013.10.002_bib0245","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJM199902183400704","article-title":"The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection","volume":"340","author":"Sieradzki","year":"1999","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.drup.2013.10.002_bib0250","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.1128\/JB.181.24.7566-7570.1999","article-title":"Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus","volume":"181","author":"Sieradzki","year":"1999","journal-title":"Journal of Bacteriology"},{"key":"10.1016\/j.drup.2013.10.002_bib0255","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1128\/jb.179.8.2557-2566.1997","article-title":"Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus","volume":"179","author":"Sieradzki","year":"1997","journal-title":"Journal of Bacteriology"},{"key":"10.1016\/j.drup.2013.10.002_bib0260","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/mdr.1999.5.253","article-title":"Inactivation of the methicillin resistance gene mecA in vancomycin-resistant Staphylococcus aureus","volume":"5","author":"Sieradzki","year":"1999","journal-title":"Microbial Drug Resistance"},{"key":"10.1016\/j.drup.2013.10.002_bib0265","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"46","author":"Soriano","year":"2008","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.drup.2013.10.002_bib0270","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1126\/science.102.2644.221","article-title":"Quantitative action of penicillin inhibitor from penicillin-resistant strains of staphylococci","volume":"102","author":"Spink","year":"1945","journal-title":"Science"},{"key":"10.1016\/j.drup.2013.10.002_bib0275","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1128\/AAC.01133-10","article-title":"Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates","volume":"55","author":"van Hal","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0280","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/infdis\/jit127","article-title":"Alternative mutational pathways to intermediate resistance to vancomycin in methicillin-resistant Staphylococcus aureus","volume":"208","author":"Vidaillac","year":"2013","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.drup.2013.10.002_bib0285","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/infdis\/jit127","article-title":"Alternative mutational pathways to intermediate resistance to vancomycin in methicillin-resistant Staphylococcus aureus","volume":"208","author":"Vidaillac","year":"2013","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.drup.2013.10.002_bib0290","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1592\/phco.29.5.511","article-title":"Ceftobiprole: first cephalosporin with activity against methicillin-resistant Staphylococcus aureus","volume":"29","author":"Vidaillac","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0295","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/AAC.01586-12","article-title":"Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic\/pharmacodynamic model","volume":"57","author":"Werth","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0300","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1128\/AAC.02308-12","article-title":"Evaluation of ceftaroline activity against heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-intermediate methicillin-resistant S. aureus strains in an in vitro pharmacokinetic\/pharmacodynamic model: exploring the \u201cseesaw effect\u201d","volume":"57","author":"Werth","year":"2013","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0305","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1128\/AAC.02354-12","article-title":"Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA (hVISA)","volume":"57","author":"Werth","year":"2013","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.drup.2013.10.002_bib0310","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1128\/AAC.00487-10","article-title":"Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the \u201cseesaw effect\u201d)","volume":"54","author":"Yang","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764613000277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764613000277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T17:05:36Z","timestamp":1646931936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764613000277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":62,"journal-issue":{"issue":"3-5","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1368764613000277"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2013.10.002","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the \u201cseesaw effect\u201d: Taking advantage of the back door left open?","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2013.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}